dr. ciccolini on dose levels of cetuximab in head and neck cancer
Published 7 years ago • 348 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
2:15
dr. ciccolini on residual concentrations of cetuximab in head and neck cancer
-
2:15
adjusting dosing to increase efficacy of cetuximab in head and neck cancer
-
4:00
incorporating cetuximab in head and neck cancer treatment
-
2:01
exploring residual concentrations of agents in head and neck cancer
-
8:56
cetuximab safety profile in head and neck cancer
-
1:12
dr. melotek on cetuximab added to chemotherapy and chemoradiation in head and neck cancer
-
10:26
cetuximab or chemotherapy in hnscc?
-
8:19
cetuximab use for hnscc
-
1:31
dr. vokes on cetuximab for head and neck cancer
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
3:28
head and neck cancer challenges & cetuximab trial updates
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
2:53
positive results for palbociclib/cetuximab therapy in head and neck cancer
-
1:15
dr. james melotek on cetuximab/chemotherapy combinations in head and neck cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
16:20
has cetuximab "selected" out in the treatment of nsclc? - dr. edward s. kim
-
4:31
cetuximab and chemoradiation
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer